NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,126 filers reported holding NOVARTIS A G in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,573,635 | +0.4% | 15,449 | -0.6% | 0.41% | +0.5% |
| Q2 2023 | $1,567,839 | +8.1% | 15,537 | -1.4% | 0.40% | +1.2% |
| Q1 2023 | $1,450,380 | +1.1% | 15,765 | -0.4% | 0.40% | -4.8% |
| Q4 2022 | $1,435,281 | +19.9% | 15,821 | +0.4% | 0.42% | +3.4% |
| Q3 2022 | $1,197,000 | -2.1% | 15,752 | +8.9% | 0.41% | -18.0% |
| Q2 2022 | $1,223,000 | -3.5% | 14,467 | +0.1% | 0.50% | +11.2% |
| Q1 2022 | $1,268,000 | -2.2% | 14,455 | -2.4% | 0.44% | +71.8% |
| Q4 2021 | $1,296,000 | +5.0% | 14,817 | -1.8% | 0.26% | -37.0% |
| Q3 2021 | $1,234,000 | -12.5% | 15,095 | -2.4% | 0.41% | -10.7% |
| Q2 2021 | $1,411,000 | +7.2% | 15,463 | +0.4% | 0.46% | -4.0% |
| Q1 2021 | $1,316,000 | -9.5% | 15,394 | 0.0% | 0.48% | -15.7% |
| Q4 2020 | $1,454,000 | +8.6% | 15,394 | 0.0% | 0.57% | -6.7% |
| Q3 2020 | $1,339,000 | -1.3% | 15,394 | -0.8% | 0.61% | -9.5% |
| Q2 2020 | $1,356,000 | +5.9% | 15,522 | -0.1% | 0.67% | -9.2% |
| Q1 2020 | $1,281,000 | -14.0% | 15,534 | -1.2% | 0.74% | +90.5% |
| Q4 2019 | $1,489,000 | +4.9% | 15,725 | -3.7% | 0.39% | -47.9% |
| Q3 2019 | $1,419,000 | -5.7% | 16,328 | -0.9% | 0.75% | +38.4% |
| Q2 2019 | $1,505,000 | -6.9% | 16,480 | -2.0% | 0.54% | -11.2% |
| Q1 2019 | $1,617,000 | +11.2% | 16,815 | -0.7% | 0.61% | -31.8% |
| Q4 2018 | $1,454,000 | -1.1% | 16,940 | -0.7% | 0.89% | +14.0% |
| Q3 2018 | $1,470,000 | +11.4% | 17,066 | -2.3% | 0.78% | +6.3% |
| Q2 2018 | $1,320,000 | -8.6% | 17,471 | -2.2% | 0.74% | -11.3% |
| Q1 2018 | $1,444,000 | -5.0% | 17,858 | -1.4% | 0.83% | -1.4% |
| Q4 2017 | $1,520,000 | -5.6% | 18,106 | -3.5% | 0.84% | -8.9% |
| Q3 2017 | $1,611,000 | +9.4% | 18,762 | +6.4% | 0.92% | +2.7% |
| Q2 2017 | $1,472,000 | +13.7% | 17,638 | +0.4% | 0.90% | +5.6% |
| Q1 2017 | $1,295,000 | -7.1% | 17,563 | -3.3% | 0.85% | -15.9% |
| Q4 2016 | $1,394,000 | 0.0% | 18,159 | 0.0% | 1.01% | -0.4% |
| Q3 2016 | $1,394,000 | -14.3% | 18,159 | -7.9% | 1.02% | -10.9% |
| Q2 2016 | $1,627,000 | – | 19,724 | – | 1.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |